180 related articles for article (PubMed ID: 32564199)
1. CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway.
Zhou R; Sun J; He C; Huang C; Yu H
Hum Cell; 2020 Oct; 33(4):1120-1132. PubMed ID: 32564199
[TBL] [Abstract][Full Text] [Related]
2. Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer.
Lu J; Zhao J; Feng H; Wang P; Zhang Z; Zong Y; Ma J; Zheng M; Lu A
Dig Dis Sci; 2014 Sep; 59(9):2153-62. PubMed ID: 24705643
[TBL] [Abstract][Full Text] [Related]
3. The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.
Peng C; Zhou K; An S; Yang J
Tumour Biol; 2015 Jan; 36(1):329-35. PubMed ID: 25256673
[TBL] [Abstract][Full Text] [Related]
4. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.
Xu B; Zhou M; Qiu W; Ye J; Feng Q
Cancer Med; 2017 May; 6(5):1062-1071. PubMed ID: 28378417
[TBL] [Abstract][Full Text] [Related]
5. AIM2 Promotes Gastric Cancer Cell Proliferation via the MAPK Signaling Pathway.
Feng X; Song Z; Huang Q; Jia J; Zhang L; Zhu M; Qian J
J Healthc Eng; 2022; 2022():8756844. PubMed ID: 35432843
[TBL] [Abstract][Full Text] [Related]
6. CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs.
Diao R; Wei W; Zhao J; Tian F; Cai X; Duan YG
Am J Reprod Immunol; 2017 Nov; 78(5):. PubMed ID: 28856757
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.
Su ML; Chang TM; Chiang CH; Chang HC; Hou MF; Li WS; Hung WC
PLoS One; 2014; 9(6):e98823. PubMed ID: 24915301
[TBL] [Abstract][Full Text] [Related]
8. Ets-1 enhances tumor migration through regulation of CCR7 expression.
Fang LW; Kao YH; Chuang YT; Huang HL; Tai TS
BMB Rep; 2019 Sep; 52(9):548-553. PubMed ID: 31072446
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 is up-regulated by CCL19/CCR7 interaction via PI3K/Akt pathway and is involved in CCL19-driven BMSCs migration.
Zhang W; Tu G; Lv C; Long J; Cong L; Han Y
Biochem Biophys Res Commun; 2014 Aug; 451(2):222-8. PubMed ID: 25086360
[TBL] [Abstract][Full Text] [Related]
10. CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck.
Zhao ZJ; Liu FY; Li P; Ding X; Zong ZH; Sun CF
Oncol Rep; 2011 Mar; 25(3):729-37. PubMed ID: 21165582
[TBL] [Abstract][Full Text] [Related]
11. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Yang X
Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
[TBL] [Abstract][Full Text] [Related]
12. CCR7/CCL19 controls expression of EDG-1 in T cells.
Shannon LA; McBurney TM; Wells MA; Roth ME; Calloway PA; Bill CA; Islam S; Vines CM
J Biol Chem; 2012 Apr; 287(15):11656-64. PubMed ID: 22334704
[TBL] [Abstract][Full Text] [Related]
13. Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21.
Liu J; Wei Y; Luo Q; Xu F; Zhao Z; Zhang H; Lu L; Sun J; Liu F; Du X; Li M; Wei K; Dong J
Int J Mol Med; 2016 Nov; 38(5):1541-1548. PubMed ID: 27666000
[TBL] [Abstract][Full Text] [Related]
14. CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer.
Xu D; Liu X; Ke S; Guo Y; Zhu C; Cao H
BMC Cancer; 2023 May; 23(1):464. PubMed ID: 37208608
[TBL] [Abstract][Full Text] [Related]
15. CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer.
Zhang Q; Sun L; Yin L; Ming J; Zhang S; Luo W; Qiu X
Tumour Biol; 2013 Oct; 34(5):2703-8. PubMed ID: 23649655
[TBL] [Abstract][Full Text] [Related]
16. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
Front Immunol; 2019; 10():2156. PubMed ID: 31572374
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.
Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W
Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma impairs chemokine-mediated dendritic cell migration in vitro.
Walker SR; Ogagan PD; DeAlmeida D; Aboka AM; Barksdale EM
J Pediatr Surg; 2006 Jan; 41(1):260-5. PubMed ID: 16410144
[TBL] [Abstract][Full Text] [Related]
19. Absent in melanoma 2 suppresses gastric cancer cell proliferation and migration via inactivation of AKT signaling pathway.
Wang D; Zou J; Dai J; Cheng Z
Sci Rep; 2021 Apr; 11(1):8235. PubMed ID: 33859277
[TBL] [Abstract][Full Text] [Related]
20. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.
Cai W; Tao J; Zhang X; Tian X; Liu T; Feng X; Bai J; Yan C; Han Y
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1933-41. PubMed ID: 24990231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
